Page last updated: 2024-11-05

4-isopropylphenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

4-Isopropylphenol, also known as p-isopropylphenol, is a colorless to pale yellow crystalline solid with a phenolic odor. It is a naturally occurring compound found in various plant sources, including thyme, oregano, and rosemary. 4-isopropylphenol exhibits antimicrobial properties and is used as a preservative in cosmetics and pharmaceuticals. It is also employed as an intermediate in the synthesis of other chemicals, such as antioxidants and pesticides. Research on 4-isopropylphenol focuses on its antimicrobial activity, potential therapeutic applications, and its role in plant defense mechanisms. Studies have investigated its effectiveness against bacteria, fungi, and viruses, as well as its potential as a natural antioxidant. The compound's bioactivity and widespread occurrence in plants make it a subject of ongoing research interest.'

Cross-References

ID SourceID
PubMed CID7465
CHEMBL ID29966
CHEBI ID167172
SCHEMBL ID28954
SCHEMBL ID8987962
MeSH IDM0092078

Synonyms (66)

Synonym
HMS1789L08
p-hydroxycumene
4-(propan-2-yl)phenol
CHEBI:167172
nsc1888
nsc-1888
4-isopropylphenol ,
p-cumenol
p-isopropylphenol
1-hydroxy-4-isopropylbenzene
wln: qr dy1 & 1
phenol, 4-(1-methylethyl)-
99-89-8
australol
phenol, p-isopropyl-
phenol, (1-methylethyl)-
einecs 202-798-8
4-(1-methylethyl)phenol
brn 1363564
prodox 133
nsc 1888
p-isopropyl phenol
para-isopropylphenol
4-iso-propylphenol
4-isopropyl phenol
inchi=1/c9h12o/c1-7(2)8-3-5-9(10)6-4-8/h3-7,10h,1-2h
4-isopropylphenol, 98%
CHEMBL29966
4-isopropyl-phenol
4-propan-2-ylphenol
4-hydroxycumene
I0262
AKOS000121483
NCGC00255837-01
cas-99-89-8
dtxcid3022299
dtxsid5042299 ,
tox21_301323
9f59joo816 ,
unii-9f59joo816
4-06-00-03215 (beilstein handbook reference)
FT-0618842
AE-562/43459027
propofol impurity h [ep impurity]
isopropylphenol, p-
AB01329173-02
SCHEMBL28954
paraisopropylphenol
SCHEMBL8987962
W-100011
STR08167
F0001-2340
mfcd00002372
p-cuminol
4-(1-methylethyl)phenol; propofol imp. h (ep); propofol impurity h
CS-0020286
NCGC00337683-01
4-iso-propylphenol-d12
h3z ,
EN300-16601
STL183327
D72532
Q27272471
1219805-27-2
Z56347200
PD065569

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" At equimolar concentrations 4-isopropylphenol was the most toxic while 4-methylphenol was the least toxic."( Quinone methide formation from para isomers of methylphenol (cresol), ethylphenol, and isopropylphenol: relationship to toxicity.
London, R; Perera, K; Thompson, DC,
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
flavouring agentA food additive that is used to added improve the taste or odour of a food.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Histone H2A.xCricetulus griseus (Chinese hamster)Potency44.98780.039147.5451146.8240AID1224845
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (20)

Assay IDTitleYearJournalArticle
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID624609Specific activity of expressed human recombinant UGT1A62000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1198413Anticandidal activity against Candida tropicalis ATCC 750 incubated at 37 degC for 24 hrs by broth dilution method2015European journal of medicinal chemistry, Mar-26, Volume: 93Synthesis, QSAR and anticandidal evaluation of 1,2,3-triazoles derived from naturally bioactive scaffolds.
AID40936Inhibition of Bacillus subtilis PCI219 spore germination, expressed as log 1/I501982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID116733Acute toxicity measured as median lethal dose in mice; Range is 40-601980Journal of medicinal chemistry, Dec, Volume: 23, Issue:12
Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agents.
AID1198412Fungicidal activity against Candida glabrata ATCC 90030 incubated at 37 degC for 48 hrs by broth dilution method2015European journal of medicinal chemistry, Mar-26, Volume: 93Synthesis, QSAR and anticandidal evaluation of 1,2,3-triazoles derived from naturally bioactive scaffolds.
AID1198409Anticandidal activity against Candida albicans ATCC 90028 incubated at 37 degC for 24 hrs by broth dilution method2015European journal of medicinal chemistry, Mar-26, Volume: 93Synthesis, QSAR and anticandidal evaluation of 1,2,3-triazoles derived from naturally bioactive scaffolds.
AID40623Inhibitory activity on germination of Bacillus subtilis PCI219 spores was determined.1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID1198411Anticandidal activity against Candida glabrata ATCC 90030 incubated at 37 degC for 24 hrs by broth dilution method2015European journal of medicinal chemistry, Mar-26, Volume: 93Synthesis, QSAR and anticandidal evaluation of 1,2,3-triazoles derived from naturally bioactive scaffolds.
AID624613Specific activity of expressed human recombinant UGT1A102000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1198414Fungicidal activity against Candida tropicalis ATCC 750 incubated at 37 degC for 48 hrs by broth dilution method2015European journal of medicinal chemistry, Mar-26, Volume: 93Synthesis, QSAR and anticandidal evaluation of 1,2,3-triazoles derived from naturally bioactive scaffolds.
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
AID114276Hypnotic activity was measured as dose which causes loss of righting reflex for a minimum period of 30s in 50% of mice; Range is 30-401980Journal of medicinal chemistry, Dec, Volume: 23, Issue:12
Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agents.
AID624610Specific activity of expressed human recombinant UGT1A72000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID26261Partition coefficient (logD7.2)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID1198410Fungicidal activity against Candida albicans ATCC 90028 incubated at 37 degC for 48 hrs by broth dilution method2015European journal of medicinal chemistry, Mar-26, Volume: 93Synthesis, QSAR and anticandidal evaluation of 1,2,3-triazoles derived from naturally bioactive scaffolds.
AID25611Dissociation constant (pKa)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID1198415Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability after 48 hrs by neutral red assay2015European journal of medicinal chemistry, Mar-26, Volume: 93Synthesis, QSAR and anticandidal evaluation of 1,2,3-triazoles derived from naturally bioactive scaffolds.
AID26793Partition coefficient (logP)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (20.00)18.7374
1990's1 (6.67)18.2507
2000's3 (20.00)29.6817
2010's5 (33.33)24.3611
2020's3 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.17 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index50.43 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]